Objects
Stevenson, William, Bryant, Jamie, Watson, Rochelle, Sanson-Fisher, Rob, Oldmeadow, Christopher, Henskens, Frans, Brown, Christina, Ramanathan, Sundra, Tiley, Campbell, Enjeti, Anoop, Guest, Johanna, Tzelepis, Flora, Paul, Christine, D'Este, Catherine. Routledge; 2020. A multi-center randomized controlled trial to reduce unmet needs, depression, and anxiety among hematological cancer patients and their support persons.
Tiong, Ing Soo, Wall, Meaghan, Marlton, Paula, Johnston, Amanda, Enjeti, Anoop, Fong, Chun Yew, Cull, Gavin, Larsen, Stephen, Kennedy, Glen, Schwarer, Anthony, Kipp, David, Ramanathan, Sundra, Bajel, Ashish, Verner, Emma, Tiley, Campbell, Morris, E, Hahn, U, Moore, J, Taper, J, Purtill, D, Warburton, P, Stevenson, W, Murphy, N, Kalro, Akash, Tan, P, Beligaswatte, A, Mutsando, H, Hertzberg, M, Shortt, J, Szabo, F, Dunne, K, Wei, AH, Australasian Leukaemia and Lymphoma Group (ALLG),, Fleming, Shaun, Roberts, Andrew W., Thiagarajah, Nisha, Chua, Chong Chyn, Latimer, Maya, Yeung, David. Nature Publishing Group; 2024. How comparable are patient outcomes in the "real-world" with populations studied in pivotal AML trials?.
Loo, Sun, Roberts, Andrew W., Taper, John, Cull, Gavin, Tiley, Campbell, Verner, Emma, Hahn, Uwe, Hiwase, Devendra K., Iland, Harry J., Murphy, Nick, Ramanathan, Sundra, Reynolds, John, Anstee, Natasha S., Ong, DM, Tiong, IS, Wall, M, Murray, M, Rawling, T, Leadbetter, J, Rowley, L, Latimer, M, Yuen, SLS, Ting, SB, Kennedy, Glen A., Fong, CY, Morris, KL, Bajel, A, Seymour, JF, Levis, MJ, Wei, AH, He, Simon, Schwarer, Anthony P., Enjeti, Anoop K., D'Rozario, James, Marlton, Paula, Bilmon, Ian A.. American Society of Hematology; 2023. Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML: a randomized, placebo-controlled study by the ALLG.